Vera Therapeutics (VERA) PT Raised to $60 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $31.97 --0%
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 33 | New: 6
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 33 | New: 6
Join SI Premium – FREE
JPMorgan analyst Anupam Rama raised the price target on Vera Therapeutics (NASDAQ: VERA) to $60.00 (from $39.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
- Qualcomm (QCOM) PT Lowered to $200 at JPMorgan
- Lumen (LUMN) PT Lowered to $6 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
